QUANTIFY CANCER
Help de-risk and accelerate your drug approval with
ctDNA-based MRD and response
monitoring.
Guardant Infinity can help bring effective new cancer therapeutics to patients—faster.
Enrich clinical trial populations to decrease
trial size and accelerate patient enrollment¹
Gain early insights into therapy response²
Develop a surrogate endpoint or determine dosing with ctDNA reduction or clearance³
ctDNA, circulating tumor DNA; MRD, molecular residual disease.
Guardant Infinity is for Research Use Only. Not for use in diagnostic procedures
Home Guardant Infinity™ for BioPharma Guardant360® CDx for BioPharma InfinityAI for BioPharma